According to results of a retrospective, real-world cohort study, glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be beneficial when used as adjunct therapy in the management of Crohns disease (CD) for patients who also have a diagnosis of overweight or obesity
The same needle, syringe and mixture is used for both subacromial and glenohumeral injections
CVS reports 50% of clients now cover GLP-1s for weight loss
At ATX Infusion and Wellness, all patients are carefully screened to determine eligibility and monitored throughout treatment to help manage side effects and optimize results
This tool evaluates key domains such as Selection, Comparability, and Exposure
CGM Time-in-Range Summary Summarise CGM percentages across very low, low, in-range, high, and very high glucose bands